Streetbeat News

Regulatory

SEEL

Seelos Therapeutics has announced that the Nasdaq Panel has granted their request for an additional period to regain compliance with Rule 5550(b)(2), allowing the company to remain listed on Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:05 pm

VTVT

Trading for VTV Therapeutics (VTVT) was halted at 4:01:47 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:01 pm

HIMS

Hims & Hers Health shares are trading lower following a report indicating the FDA issued a warning on compounding GLP-1 adverse events.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 7:37 pm

TSNDF

Boone Town Provisions, Boonton's first retail cannabis shop, is set to open after overcoming regulatory and local challenges. The shop, founded by Jamie Singer and her brother-in-law Justin Singer, aims to destigmatize cannabis use and promote health and wellness. The grand opening will feature live bands, product discounts, and giveaways, including products from TerrAscend (OTC:TSNDF).

Portfolio Pulse from Juan Spínelli

July 26, 2024 | 7:34 pm

EWA

FXI

INDA

SPY

U.S. Treasury Secretary Janet Yellen stated that the United Nations lacks the expertise to handle global tax issues and involves too many countries. She mentioned that significant progress has been made in the Pillar 1 talks on digital taxes, but India, China, and Australia are still holding out.

Portfolio Pulse from charles@benzinga.com

July 26, 2024 | 6:38 pm

SPY

Treasury Secretary Yellen opposes shifting global tax agreement negotiations from the OECD to the UN, as stated in a Reuters interview.

Portfolio Pulse from charles@benzinga.com

July 26, 2024 | 6:37 pm

SPY

U.S. Treasury Secretary Janet Yellen announced that the G7 is likely to agree on $50 billion loan terms for Ukraine by October. The U.S. Treasury requires assurance that frozen Russian assets will cover the loan, not U.S. taxpayers. The EU is working on alternatives to meet sanctions and U.S. needs.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 6:25 pm

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trending as the company is set to release its 2024 fiscal year and fourth quarter earnings on Monday. Analysts estimate a loss of 2 cents per share and revenue of $227.07 million. The stock is currently trading at $1.81, close to its 50-day moving average of $1.8 and on the lower end of its 52-week range of $1.6 to $3.4. Recently, Tilray received approval for a medical cannabis extract in Portugal and saw a 6.70% increase in stock price following President Biden's announcement that he is not seeking re-election.

Portfolio Pulse from Dylan Berman

July 26, 2024 | 6:21 pm

AMZN

Amazon.com, Inc. (NASDAQ:AMZN) is under dual investigations in Italy for alleged tax evasion and labor violations. Italian authorities have seized €121 million from Amazon Italia Transport in Milan, accusing the unit of dodging labor and tax laws. Another investigation, unrelated to the first, is also probing Amazon for suspected tax evasion related to trading goods within Italy and internationally.

Portfolio Pulse from Michael Juliano

July 26, 2024 | 6:19 pm

AQST

Aquestive Therapeutics shares are trading higher after the company released positive topline PK data from the self-administration study of Anaphylm, meeting primary endpoints. The final OAS challenge study is enrolling, and a pre-NDA meeting is expected by the end of Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 6:14 pm